Physician profile
Ashwin M Raghavan
NPI 1679000327
$7,208.54
in general payments reported to CMS, 2019-2025
23 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.40 · 2020: $89.96 · 2021: $201 · 2022: $2,341 · 2023: $1,722 · 2024: $1,524 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396 · Travel and Lodging: $2,052 · Education: $35.06 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,396.18 |
| Travel and Lodging | $2,052.21 |
| Education | $35.06 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,409.44 | 2019-2022 | |
| Teleflex LLC | $1,796.81 | 2024-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $1,723.61 | 2023-2024 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $136.86 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $123.46 | 2022-2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $117.85 | 2022 | |
| Olympus America INC. | $102.56 | 2023 | Itind System, Soltive |
| Immunitybio, INC. | $92.74 | 2024-2025 | |
| Coloplast Corp | $89.96 | 2020 | |
| Sumitomo Pharma America, INC. | $86.78 | 2023-2025 | Orgovyx, Myfembree, Gemtesa |
| Antares Pharma, INC. | $71.08 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $67.84 | 2024-2025 | |
| Convatec INC. | $65.76 | 2025 | |
| Janssen Biotech, INC. | $62.30 | 2024-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $52.17 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $43.18 | 2024-2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Valencia Technologies Corporation | $30.39 | 2025 | Ecoin Device Kit |
| Edap Technomed INC | $27.98 | 2025 | |
| Urogen Pharma, INC. | $23.56 | 2025 | |
| Blue Earth Diagnostics | $19.07 | 2025 | Posluma |
| Endo USA, INC. | $16.33 | 2025 | Xiaflex |
| Amgen INC. | $13.75 | 2024 | Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwin Raghavan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.